首页> 外文期刊>The Medical Clinics of North America >Current status of diuretics, beta-blockers, alpha-blockers, and alpha-beta-blockers in the treatment of hypertension.
【24h】

Current status of diuretics, beta-blockers, alpha-blockers, and alpha-beta-blockers in the treatment of hypertension.

机译:利尿剂,β受体阻滞剂,α受体阻滞剂和αβ受体阻滞剂在高血压治疗中的现状。

获取原文
获取原文并翻译 | 示例
       

摘要

The article describes the current status of four main antihypertensives. Diuretics are making a bit of a comeback after seeing their popularity wane during the 1980s. beta-blockers also saw a bit of a popularity decrease in the 1980s due to some adverse side effects which the author feels were somewhat exaggerated. alpha-blockers have yet to be particularly successful in the treatment of hypertension, due to adverse side effects. alpha-beta-blockers appear to hold significant promise in the further treatment of hypertension.
机译:本文介绍了四种主要的降压药的现状。在看到利尿剂在1980年代的普及度下降之后,它正在卷土重来。由于某些不利的副作用,β受体阻滞剂在1980年代也有所减少,作者认为有些夸大了。由于不利的副作用,α-受体阻滞剂尚未在治疗高血压方面特别成功。 α-β受体阻滞剂在高血压的进一步治疗中似乎具有重大前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号